Panel Discussion of the new ACC/AHA Hypertension Guidelines and the Impact on Renal Denervation Therapy

Date
Thursday, September 25, 2025
 
Time
7:00 PM (UTC-04:00) Eastern Time (US & Canada)
 
Duration
60 minutes
 
Description

Join an expert multi-specialty panel as they discuss the newly announced ACC/AHA Guidelines and the impact the guidelines will have on treating Hypertension with Renal Denervation Therapy. Learn from the experts as they discuss the new guidelines and their impact on treating Hypertension with Renal Denervation Therapy. In this webinar, Yvonne Commodore-Mensah Phd, RN; Luke Laffin MD, Eric Secemsky MD and Raven Voora MD will be discussing the impacts on:

  • Facilities and Institutions
  • Patient Selection
  • Patient Care and Pathway Planning
  • Administration Considerations
  • Referrals for the Therapy
  • And more 

 

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.

 

 

UC202601620 IE ©2025 Medtronic. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.

Sponsored by:

Speakers

Yvonne Commodore-Mensah, PhD, MHS, RN, FAAN, FAHA, FPCNA
Yvonne Commodore-Mensah, PhD, MHS, RN, FAAN, FAHA, FPCNA
Johns Hopkins School of Nursing and Bloomberg School of Public Health
Professor/Associate Dean for Research

Luke Laffin, MD
Luke Laffin, MD
Center for Blood Pressure Disorders, Cleveland Clinic
Co-Director

Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM
Beth IDMC
Director of Vascular Intervention

Raven Voora, MD
Raven Voora, MD
UNC Hypertension Clinic
Nephrologist, Hypertension Specialist